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ABSTRACT 
Orexin plays a crucial role in drug-seeking behavior. The lateral hypothalamus (LH) is a cen-
tral region that produces orexin, and its projections to the ventral tegmental area (VTA) play 
an important role in reward and addiction-related behaviors. In this study, we investigated the 
role of LH stimulation and the involvement of the orexin-1 receptor (Ox1r) in the VTA in re-
lation to morphine sensitization. In all animals, cannulae were implanted unilaterally into the 
LH and VTA to inject different doses of carbachol (62.5, 125 and 250 nmol/0.5 μl saline) as a 
cholinergic agonist and SB334867 (1, 10 and 20 nmol/0.3 µl DMSO) as a selective Ox1r an-
tagonist for three consecutive days (sensitization period) respectively. These drugs were in-
jected five minutes before administration of an ineffective dose of morphine (0.5 mg/kg; sc) 
during the sensitization period. In all groups, the sensitization period occurred in a separate 
room from which the conditioning occurred. After this period, all groups exceeded five days 
under the conditioned place preference (CPP) paradigm without any treatment. For evaluation 
of morphine sensitization, place preference was induced by ineffective dose of morphine (0.5 
mg/kg) and the CPP score was represented by the difference in time spent in drug- and saline-
paired compartments. The results revealed that concurrent intra-LH administration of car-
bachol (125 nmol/0.5 µl saline) and an ineffective dose of morphine (0.5 mg/kg) significantly 
induce CPP. Additionally, the blockade of Ox1r in the VTA by SB334867 can attenuate the 
conditioning score induced by concurrent administration of carbachol and an ineffective dose 
of morphine. Our findings suggest that LH stimulation potentiates the effect of an ineffective 
dose of morphine, and induces morphine sensitization. It seems that the chemical stimulation 
of LH potentiates sensitization to morphine through the orexinergic system in the VTA in 
rats. 
 
Keywords: Morphine sensitization, orexin, lateral hypothalamus, ventral tegmental are,  
carbachol, SB334867 
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INTRODUCTION 
In 1998, orexin A and B were recognized 
as neurotransmitters produced in the hypo-
thalamic neurons. Since then considerable 
research has been undertaken to characterize 
this neurotransmitter system. Orexin-1 re-
ceptor (Ox1r) and orexin-2 receptor (Ox2r) 
were discovered shortly afterwards (Sakurai 
et al., 1998) while Sakurai also showed orex-
ins to be involved in reward processing. It 
appears that orexin shave a prominent role in 
the conditioned response to stimuli associat-
ed with food and drug rewards (Aston-Jones 
et al., 2009) and in opiate withdrawal 
(Georgescu et al., 2003).They are also in-
volved in drug-seeking behavior elicited by 
context association with drugs. The lateral 
hypothalamus (LH) is a main region for pro-
ducing orexins, and these neurons and their 
projections to the ventral tegmental area 
(VTA) play a crucial role in reward pro-
cessing, drug abuse and addiction-related 
behaviors (Stephen et al., 2011). Stimulation 
of LH orexin neurons, or microinjection of 
orexin into the VTA, has been shown to re-
instate an extinguished morphine preference. 
Modulation of forebrain dopamine neu-
rotransmission is one of the key means of 
leading VTA orexin to increase conditioned 
reward seeking, which is tied to reward seek-
ing and approach effort (Berridge and Rob-
inson, 1998; Cheer et al., 2007; Fiorillo et 
al., 2003). Orexin can activate mesolimbic 
dopamine neurons, especially those located 
in the VTA (Korotkova et al., 2003; Narita et 
al., 2007). This activation results in dopa-
mine release in the nucleus accumbens 
(NAc) as a main cause of reward. Fos activa-
tion in VTA-projecting LH orexin neurons 
correlates with the intensity of reward during 
protracted abstinence (Harris and Aston-
Jones, 2003). Orexin input to the VTA may 
contribute to the propensity of relapse during 
protracted abstinence in addicts (Aston-Jones 
et al., 2010). 
The enhanced response to a stimulus, af-
ter repeated exposure to that stimulus, is 
termed sensitization (Robinson and Becker, 
1986; Kalivas and Stewart, 1991). Sensitiza-
tion is suggested to play an effective role in 
the psychopathology of drug abuse (Robin-
son and Becker, 1986; Shippenberg et al., 
1996). Repeated concomitant morphine ad-
ministration causes sensitization to its re-
warding effects (Carlezon et al., 1997). Mor-
phine-induced sensitization is a major prob-
lem of morphine dependence and involves 
opioid drug abuse liability (Robinson and 
Becker, 1986). This enhanced response ap-
pears to be related to changes in the meso-
limbic dopamine (DA) pathway, which aris-
es in the VTA and projects mainly to the 
NAc (Kalivas and Duffy, 1993). Behavioral 
sensitization has been shown to be involved 
in the locomotor stimulant, rewarding and 
discriminative effects of morphine (Kuribara, 
1997). Some behavioral studies have demon-
strated that orexin injection into the VTA 
reinstates an extinct morphine and cocaine 
preference (Harris et al., 2005; Wang et al., 
2009), and blockade of Ox1r in the VTA 
weakens cue-induced cocaine reinstatement 
(James et al., 2011) but not stress-induced 
cocaine reinstatement (Wang et al., 2009) 
The LH has a central role in morphine an-
tinociception and pain relief effects, and also 
synthesizes orexin selectively (Georgescu et 
al., 2003). Furthermore, orexin-A has been 
reported to produce an analgesic effect in 
pain models, which was blocked by the orex-
in-1 receptor antagonist SB-334867, but not 
naloxone. Our previous study showed that 
morphine’s analgesic effect in the formalin 
test might also be associated with the orexin-
1 receptor (Azhdari-Zarmehri et al., 2013). 
In this study, we tried to evaluate the effect 
of LH stimulation and the orexinergic system 
within the VTA on sensitization to morphine 
in rats. 
 
MATERIALS AND METHODS 
Animals 
One hundred and nine adult male albino 
Wistar rats (Pasteur Institute, Tehran, Iran) 
weighing 210–280 g were used in this exper-
iment. Animals were housed in groups of 
three per cage in a 12/12 h light/dark cycle 
(light on between 7:00 a.m. and 7:00 p.m.) 
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with free access to chow and tap water. The 
animals were randomly allocated to different 
experimental groups. Each animal was used 
only once. Rats were habituated to their new 
environment and handled for 1 week before 
the experimental procedure was started. All 
experiments were executed in accordance 
with the Guide for the Care and Use of La-
boratory Animals (National Institutes of 
Health Publication No. 80-23, revised 1996) 
and were approved by the Research and Eth-
ics Committee of Shahid Beheshti University 
of Medical Sciences, Tehran, Iran. 
 
Drugs 
In the present study the following drugs 
were used: Carbachol, as a cholinergic ago-
nist (Sigma-Aldrich, USA) was dissolved in 
normal saline. SB-334867, as an Ox1r an-
tagonist (Tocris Bioscience, Bristol, UK) 
was dissolved in dimethyl sulfoxide (DMSO; 
Sigma-Aldrich, Germany) as a vehicle and 
morphine sulfate (Temad, Iran) dissolved in 
sterile saline (0.9 %). 
 
Stereotaxic surgery 
Rats were anesthetized by intraperitoneal 
injection of Xylazine (10 mg/kg) and Keta-
mine (100 mg/kg), and placed into stereotax-
ic device (Stoelting, USA). An incision was 
made along the midline, the scalp retracted, 
and the area surrounding bregma was 
cleaned and dried. In addition, lidocaine with 
epinephrine (0.2 ml) was injected in several 
locations around the incision. Stainless steel 
guide (23-gauge) cannulae 11 mm in length 
were aimed to the LH and/or VTA unilateral-
ly stereotaxic coordinates: incisor bar  
-3.3 mm, -3 mm posterior to the bregma, 
±1.6 mm lateral to the sagittal suture and 
8.8 mm down from top of the skull for LH, 
and for VTA, we use this coordination AP=  
-4.8 mm caudal to bregma, Lat = ± 0.9 mm 
lateral to midline, DV=8.3 mm ventral from 
the skull surface. Cannulae were secured 
with jewelers’ screws and dental acrylic ce-
ment. After the cement was completely dried 
and hardened, two stainless steel stylets were 
used to occlude the guide cannulae during 
recovery period. Penicillin-G200000 IU/ml 
(0.2–0.3 ml/rat, single dose, intramuscular) 
were administered immediately after surgery. 
Animals were individually housed and al-
lowed to recover for 5 days before experi-
ments. 
 
Drug administration 
Microinjections were performed through 
the 30-gauge injector cannulae (1 mm below 
the tip of the guide cannulae). Polyethylene 
tubing (PE-20) was used to attach injector 
cannula to the 1-µl Hamilton syringe. For 
drug microinjection, the animals were gently 
restrained by hand; the stylets were removed 
from the guide cannulae and replaced by 30-
gauge injector cannulae. Carbachol adminis-
tered slowly in a total volume of 0.5 µl/rat 
over a period of 60 s and SB334867 solu-
tions (with 10 % DMSO as a vehicle) were 
administered in a total volume of 0.3 µl/rat 
over a period of 60 s into the VTA. Injection 
needles were left in place for an additional 
60 s to facilitate drug diffusion, and then the 
stylets were reinserted into the guide cannu-
lae. 
 
Induction of morphine sensitization 
For basic induction of morphine sensiti-
zation, effective dose of morphine (5 mg/kg; 
sc) was injected once daily for three days as 
the sensitization period followed by five 
days free from morphine treatment. Howev-
er, in the present study, for induction of 
morphine sensitization, we concurrently in-
jected an ineffective dose of morphine and 
intra-LH carbachol during sensitization peri-
od. After sensitization period and 5-day free 
drug period, the CPP paradigm was done. In 
this CPP protocol we used ineffective dose 
of morphine during conditioning phase for 
evaluating the occurrence of sensitization 
that will be explained in the following sec-
tion. 
 
Conditioned place preference paradigm 
A three-compartment conditioned place 
preference (CPP) apparatus (30 cm × 30 cm 
× 40 cm) was used in these experiments 
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(Haghparast et al., 2009). Place conditioning 
was conducted using an unbiased procedure. 
The apparatus was made of Plexiglas (Borj 
Sanat, Iran) and divided into two equal-sized 
compartments by means of a removable 
white wall and shading (both were white), 
but distinguishable by texture. To provide 
the tactile difference between the compart-
ments, one of the compartments had a 
smooth floor while the other compartment 
had a net-like floor. Two preference com-
partments were differently striped black and 
white on their walls. The null compartment 
was a tunnel (30 cm × 15 cm × 40 cm) con-
necting the two preference compartments. In 
this apparatus, rats showed no consistent 
preference for either compartment, which 
supports our unbiased CPP paradigm. This 
paradigm took place in five consecutive 
days, which consisted of three distinct phas-
es: pre-conditioning, conditioning and post-
conditioning. For all phases, animals were 
tested during the same time period each day. 
 
Pre-conditioning phase 
On day 1, each rat was placed separately 
into the apparatus for 10 min, with free ac-
cess to all compartments. The time spent in 
each compartment and the rats’ movements 
were recorded (pre-test day). Animals were 
then randomly assigned to one of the two 
compartments for place conditioning. 
 
Conditioning phase 
This phase started 1 day after pre-
conditioning phase. It consisted of six, 
30 min sessions (three saline and three drug 
pairing) in a 3-day schedule. These sessions 
were conducted twice each day (from day 2 
to day 4) with a 6 h interval. On each day, 
separate groups of animals received a condi-
tioning session with drug and another with 
saline. During sessions, the animals were 
confined to one compartment by closing the 
removable wall. Treatment compartment and 
order of presentation of drug/saline were 
counterbalanced for either group. 
Post-conditioning or testing phase 
This phase was carried out on day 5 (the 
preference test day), 1 day after the last con-
ditioning session, in a drug free state. Each 
animal was tested only once. The removable 
wall was removed for testing and rats were 
allowed to access the entire apparatus for 
10 min. For each rat, the time spent in each 
compartment during a 10 min period was 
recorded by a 3CCD camera (Panasonic Inc., 
Japan) and analyzed using the Ethovision 
software (XT, Version 7), a video tracking 
system for automation of behavioral experi-
ments (Noldus Information Technology, the 
Netherlands). The conditioning score, as a 
preference index, was calculated as the time 
spent in the drug-paired compartment minus 
the time spent in saline-paired compartment. 
Total distance traveled by each animal was 
also recorded in all control and experimental 
groups. 
 
Conditioning score measurement 
Conditioning scores (CPP score) repre-
sent the time spent in drug-paired compart-
ment minus the time spent in the saline-
paired compartment (Azizi et al., 2009) dur-
ing 10 min (600 s) post-conditioning test. In 
this study, CPP score is used for evaluating 
the effect of drugs on morphine-induced 
place preference in morphine-sensitized and 
saline-treated non-sensitized rats. 
 
Experimental design 
To evaluate the sensitization to mor-
phine, moderate chemical stimulation of the 
LH by carbachol and ineffective dose of 
morphine were applied for three consecutive 
days (sensitization period) in a room distinct 
from which the conditioning occurred. Five 
days later, the CPP paradigm was induced by 
ineffective doses of morphine (0.5 mg/kg; 
sc). 
 
Morphine dose-response on place  
conditioning paradigm in sensitized rats 
To choose the ineffective dose of mor-
phine for the next experiments, the condi-
tioned place preference was done by graded 
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ineffective doses of morphine (0.25 and 
0.5 mg/kg) in animals, which had previously 
received once daily morphine (5 mg/kg; sc) 
for 3 consecutive days (sensitization period). 
Place conditioning commenced 5 days later. 
Control animals received saline (1 ml/kg; sc) 
instead of morphine during sensitization pe-
riod. Conditioning score and distance trav-
eled were recorded and analyzed during 
10 min, on the pre- and post-conditioning 
phases. 
 
Effect of concurrent administration of 
morphine and intra-LH carbachol on 
development of morphine sensitization in 
CPP paradigm 
In this set of experiments, two super 
groups described and each group contained 
three groups. In both super groups different 
doses of carbachol (62.5, 125 and 250 nmol/ 
0.5 µl saline; n = 5-7 in each group) mi-
croinjected unilaterally into the LH for stim-
ulating this region for three consecutive days 
(Taslimi et al., 2012). Also, these super 
groups concurrently received saline or inef-
fective dose of morphine during the sensiti-
zation period. After the 5-day free of drug 
injections, the CPP paradigm was done for 
evaluating the morphine sensitization in this 
protocol. In conditioning phase, morphine 
was applied at the ineffective dose selected 
from the previous mentioned experiments. 
On the post-conditioning test, conditioning 
score and distance traveled were calculated 
for each rat in all morphine- and saline-
treated groups. 
 
The effects of Ox1r antagonist SB334867 
microinjected into the VTA on LH 
stimulation-induced sensitization in rats 
To find out the role of Ox1r in the VTA 
in morphine sensitization induced by chemi-
cal stimulation of LH, different doses of 
SB334867 (1, 10 and 20 nmol/0.3 µl DMSO; 
n = 6 in each group) were microinjected just 
before the concurrent administration of intra-
LH carbachol and systemic morphine 
(0.5 mg/kg, sc) during the sensitization peri-
od. In respective control groups, animals re-
ceived saline instead of carbachol and mor-
phine. As described in previous section, after 
the 5-day free of drug injections, the CPP 
paradigm was done for evaluating the mor-
phine sensitization in this protocol. In condi-
tioning phase, morphine was applied at the 
ineffective dose. Then, conditioning score 
and distance traveled were calculated for 
each rat in all morphine- and saline-treated 
groups on the test day. 
 
Locomotor activity measurement 
To evaluate the effect of drugs on loco-
motor activity in morphine- and saline-
treated animals, total distance traveled (cm) 
during a 10 min period, on the pre- and post-
conditioning phases was measured. 
 
Histology 
After performing the test, the animals 
were deeply anesthetized with Ketamine and 
Xylazine. Then, they were transcardially per-
fused with 0.9 % saline and 10 %formalin 
solution. The brains were removed, blocked 
and cut coronally in 50 µm sections through 
the cannulae placements. The neuroanatomi-
cal location of cannulae tips placements, 
were confirmed using Paxinos and Watson 
rat brain atlas (Paxinos and Watson, 2007). 
Only the animals with correct cannulae 
placements were included in the data analy-
sis. 
 
Statistics 
Conditioning score represents the differ-
ences between the time spent in drug-paired 
compartment and the time spent in the sa-
line-paired compartment, and is expressed as 
mean ± SEM (standard error of mean). Data 
were processed by commercially available 
software GraphPad Prism® 5.0. In order to 
compare the conditioning scores and dis-
tance traveled obtained in all groups (vehicle 
and experimental groups), one-way analysis 
of variance (ANOVA) and randomized 
blocks model followed by post-hoc analysis 
(Dunnett or Newman-Keuls test) were used, 
as appropriated. P-values less than 0.05 
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(P<0.05) were considered to be statistically 
significant. 
RESULTS 
Morphine dose-response on place  
conditioning paradigm in sensitized rats 
Figure 1 shows the conditioned place 
preference produced by graded doses of 
morphine (0.25 and 0.5 mg/kg) in rats, which 
had previously received morphine (5 mg/kg; 
sc) once daily for three consecutive days. 
Place conditioning commenced five days lat-
er. In animals with a previous history of 
morphine administration, an enhanced re-
sponse to morphine was observed. The max-
imum response was observed at the mor-
phine dose of 0.5 mg/kg [F (6,48) = 8.063, 
P<0.0001; Figure 1]. Therefore, the dose of 
0.5 mg/kg of morphine was selected as the 
appropriate dose for the rest of the experi-
ments in the CPP paradigm in morphine-
sensitized rats. Injection of saline (1 ml/kg; 
sc) instead of morphine (5 mg/kg) during the 
sensitization days did not produce any sensi-
tization in the animals. 
 
Figure 1: Effects of repeated concomitant mor-
phine administration on the animal sensitivity to 
low doses of morphine (i.e. sensitization). Ani-
mals received three morphine (5 mg/kg; sc) in-
jections in three consecutive days following 5 
days of resting. After this period, these animals 
were conditioned to ineffective doses of mor-
phine (0.25 and 0.5 mg/kg; sc). As indicated in 
this figure, animals with previous history of mor-
phine showed prominent response to low doses 
of morphine compared with saline-treated rats. 
Each point shows the mean ± SEM for 5 rats.  
** P<0.01 different from the saline control group 
Effect of concurrent administration of 
morphine and intra-LH carbachol on 
development of morphine sensitization in 
the CPP paradigm 
To determine the effects of LH stimula-
tion for induction of morphine sensitization 
in the CPP paradigm, carbachol (62.5, 125 
and 250 nmol/0.5 µl saline; n = 6-7 in each 
group) was unilaterally administered into the 
LH during the sensitization period of exper-
iments. One-way ANOVA followed by 
Newman-Keuls multiple comparison test in-
dicated that using carbachol alone (62.5, 125 
and 250 nmol/ 0.5 µl saline) for stimulating 
LH could not induce morphine sensitization 
and had no effect on morphine-induced CPP 
in the animals [F (4,24) = 0.5757, P = 
0.6835; left panel Figure 2].  
 
Figure 2: Effects of unilateral administration of 
different doses of carbachol into the lateral hypo-
thalamus (LH) during sensitization period on 
conditioned place preference in saline (left panel) 
and morphine (right panel) treated animals that 
received saline (1 mg/kg; sc) or ineffective mor-
phine (0.5 mg/kg; sc) during sensitization period 
respectively. Each point shows the mean ± SEM 
for 5-7 rats. * P<0.05 and ** P<0.01 different 
from the saline control group †† P<0.01 different 
from the respective vehicle group 
 
In the right panel in Figure 2, the effect 
of concurrent administration of morphine 
and carbachol during the sensitization period 
of the CPP paradigm is shown. In this set of 
experiments, different doses of carbachol 
(62.5, 125 and 250 nmol/ 0.5 µl saline) were 
injected into the LH during the sensitization 
period, five minutes prior to each ineffective 
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dose of morphine (0.5 mg/kg; sc). One-way 
ANOVA indicated that simultaneous admin-
istration of carbachol (125 and 250 nmol) 
and ineffective dose of morphine 
(0.5 mg/kg) significantly induced CPP com-
pared to saline (0.5 µl/side) during the induc-
tion of sensitization [F (4,27) = 7.552, P = 
0.0005; Figure 2] in a dose-dependent man-
ner. On the other hand, one-way ANOVA 
indicated that on the test day, none of the 
groups showed significant differences in lo-
comotor activity (Figure 3). 
 
Figure 3: Effects of concurrent administration of 
different doses of carbachol into the lateral hypo-
thalamus (LH) and saline/morphine during sensi-
tization period on locomotor activity saline (left 
panel) and morphine (right panel) treated ani-
mals. Each point shows the mean ± SEM for 5-7 
rats. 
 
The effects of Ox1r antagonist SB334867 
microinjected into the VTA on LH 
stimulation-induced sensitization in rats 
In this set of experiments, to establish the 
role of orexin-1 receptor in the VTA by LH 
stimulation-induced sensitization to mor-
phine, intra-VTA orexin receptors were 
blocked with different doses of SB334867 
(1,10 and 20 nmol/0.3 µl DMSO) during the 
sensitization period, five minutes before 
concurrent administration of intra-LH car-
bachol (125 nmol/ 0.5 µl saline) and mor-
phine (0.5 mg/kg; sc). As shown in Figure 4, 
one-way ANOVA followed by the Newman-
Keuls multiple comparison test indicated the 
blockade of orexin-1 receptor in the VTA to 
dependently attenuate conditioning scores 
compared with the DMSO control group, in 
which animals received only DMSO instead 
of SB334867 [F (5,35) = 9.297, P<0.0001; 
Figure 4]. Additionally, microinjection of the 
maximal dose of SB334867 into the VTA 
(20 nmol) alone during the sensitization pe-
riod did not affect the conditioning score 
(left bar, Figure 4). On the other hand, one-
way ANOVA indicated that none of the 
groups showed significant differences in lo-
comotor activity on the test day. Thus, intra-
VTA administration of different doses of 
SB334867 did not affect the conditioning 
scores due to changes in locomotor activity 
[F (5,35) = 0.1731, P=0.9706; Figure 5]. 
 
 
Figure 4: Effects of orexin-1 receptor antagonist 
SB334867 (1, 10 and 20 nmol/0.3 µl DMSO) mi-
croinjected into the ventral tegmental area (VTA) 
prior concurrent administration of carbachol 
(125 nmol/rat) into the lateral hypothalamus (LH) 
and morphine (0.5 mg/kg) during sensitization 
period on conditioning score in conditioned place 
preference paradigm. Each point shows the 
mean ± SEM for 6 rats. * P<0.05 and ** P<0.01 
different from the saline control group 
† P<0.05 and †† P<0.01 different from the respec-
tive vehicle group 
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Figure 5: Effects of orexin-1 receptor antagonist 
SB334867 (1, 10 and 20 nmol/0.3 µl DMSO) mi-
croinjected into the ventral tegmental area (VTA) 
prior concurrent administration of carbachol 
(125 nmol/rat) into the lateral hypothalamus (LH) 
and morphine (0.5 mg/kg) during sensitization 
period on locomotor activity in conditioned place 
preference paradigm. Each point shows the 
mean ± SEM for 6 rats. 
 
DISCUSSION 
The aim of this study was to investigate 
the role of orexinergic outputs from the lat-
eral hypothalamus to the ventral tegmental 
area in morphine sensitization in rats. This 
study indicates that (i) concurrent admin-
istration of intra-LH carbachol and ineffec-
tive dose of systemic morphine during the 
sensitization period can potentiate the re-
warding effect of morphine (morphine sensi-
tization) while (ii) injection of different dos-
es of carbachol alone in the LH during the 
sensitization period cannot affect the acquisi-
tion of morphine-induced CPP and (iii) the 
blockade of the orexin-1 receptor in the VTA 
significantly reduces the potentiating effect 
of LH stimulation on morphine sensitization. 
On the other hand, the drugs do not affect 
locomotor activity in any groups. 
The development of behavioral sensitiza-
tion can be separated into two phases: initia-
tion and expression. The initiation phase 
marks the immediate neural events that in-
duce behavioral sensitization, and is com-
monly linked to the VTA. The expression 
phase is the long-term consequence of this 
initiation and is linked to the NAc (Kalivas 
and Weber, 1988). The NAc serves as an 
output pathway to motor circuits. In the case 
of sensitization, the NAc is modulated by 
dopamine input from the VTA that either 
directly innervates this target or does so indi-
rectly via the paraventricular nucleus (PVN) 
and basolateral amygdala (BLA). Previous 
studies have shown that orexin-1 and -2 re-
ceptors exist on dopaminergic and GABAer-
gic neurons in the VTA and NAc (Sharf et 
al., 2008), so the activation of orexin recep-
tors in the VTA after the stimulation of LH 
results in the activation of dopaminergic neu-
rons in the cell bodies and dendrites of the 
mesolimbic pathway (Narita et al., 2006). 
Additionally, the intra-VTA injection of 
orexin may cause an increase in dopamine in 
the NAc (Pontieri et al., 1995): stimulation 
of the orexinergic receptor in the VTA may 
cause an increase in the activity of dopamin-
ergic neurons followed by an increase in the 
amount of dopamine in the NAc. Although 
the ineffective dose of morphine could not 
release sufficient dopamine levels in the 
VTA and NAc, orexin was shown to com-
pensate by increasing the release of dopa-
mine in these regions. Our study shows that 
to develop the initiation phase of sensitiza-
tion, collaboration between the opioid re-
ward system and orexinergic system is nec-
essary. Our findings also reveal that orexin 
release in the VTA is necessary but not suf-
ficient for inducing morphine sensitization. 
The NAc receives indirect glutamate pro-
jections via the VTA (Steketee and Kalivas, 
2011). Electrophysiological studies have 
shown that a drug-induced change in the 
VTA is consistent with enhancement of glu-
tamate transmission mediating the develop-
ment of behavioral sensitization. Moreover, 
other neurotransmitters in the VTA, such as 
orexin, modulate glutamatergic transmission 
in the VTA and regulate drug self-
administration (Borgland et al., 2006). It is 
documented that stimulation of D1 dopamine 
receptors in the VTA is necessary for sensi-
tization to systemic psychostimulant admin-
istration (Vezina, 1996). By the mid-1990s it 
was proposed that stimulation of D1 recep-
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tors is linked to the release of glutamate in 
the VTA as a necessary sequence of synaptic 
events to induce sensitization (Kalivas and 
Duffy, 1995), and in a recent study using 
measurements of N-Methyl-D-aspartate 
(NMDA) currents it has been shown that D1-
mediated increases in NMDA currents on 
dopamine neurons result from a direct post-
synaptic action to increase surface expres-
sion of NMDA receptors (Schilstrom et al., 
2006). These authors speculated that the rise 
in pre-synaptic glutamate release might re-
sult from increased activation of dopamine 
cells via an increase in NMDA receptor ac-
tivity relating to the prefrontal glutamatergic 
input to the VTA. 
Ox1r activation in dopaminergic neurons 
in the VTA is required for the development 
of behavioral sensitization as well as for the 
induction of synaptic plasticity at excitatory 
synapses associated with sensitization. The 
orexin system is involved in the reward pro-
cess and addiction because it has a connec-
tion with reward-related areas such as the 
VTA and NAc. Previous studies have 
demonstrated that orexin administration into 
the VTA can increase CPP and dopamine 
release in the NAc (Narita et al., 2006, 2007; 
Taslimi et al., 2011). We have shown that 
chemical activation of LH orexin neurons 
can be rewarding for animals not receiving 
drugs as reward inducers. This effect is me-
diated at least in part by VTA synapses, as it 
can be blocked by pharmacological inactiva-
tion of Ox1r in the VTA (Taslimi et al., 
2011). We have also revealed that despite the 
rewarding effect of lone chemical stimula-
tion of LH by carbachol (Taslimi et al., 
2011), the same LH stimulation during the 
sensitization period does not affect the ac-
quisition of an ineffective dose of morphine-
induced CPP, while chemical stimulation of 
LH and an ineffective dose of morphine ad-
ministration simultaneously can increase the 
conditioning response induced by morphine, 
and blockade of the VTA orexin-1 receptor 
can significantly decrease the potentiating 
effect of LH stimulation on morphine sensi-
tization. To develop the initiation phase of 
sensitization, therefore, collaboration be-
tween the opioid reward system and orex-
inergic system is necessary, while orexin re-
lease in the VTA is necessary but not suffi-
cient to induce morphine sensitization in 
rats. 
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